Is There Still a Role for First-Line Single Agent Endocrine Therapy in HR+ and HER2- Advanced Breast Cancer?
Breast Care (Basel)
.
2017 Oct;12(5):288-289.
doi: 10.1159/000484259.
Epub 2017 Oct 25.
Authors
Luca Malorni
1
2
,
Laura Biganzoli
2
Affiliations
1
'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy.
2
'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy.
PMID:
29234246
PMCID:
PMC5704686
DOI:
10.1159/000484259
No abstract available
Publication types
Editorial